The new price of Praluent will be $5,850 per year, which will match the price Amgen set when it lowered the price of its competing cholesterol drug Repatha last year.
The decision to lower the price comes as the drugmakers hope to increase use of the cholesterol drug. In recent years, sales have lagged because of roadblocks insurers use to limit spending on expensive drugs.
Sanofi and Regeneron expect the lower-priced drug to be available in March.
More articles on pharmacy:
Generic drugmakers urged to boost lobbying efforts
4 big pharma CEOs agree to testify at February drug-pricing hearing
Walgreens pays nearly $2M to settle claims with MassHealth
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
